Taylor & Francis

Irina Armean from the European Bioinformatics Institute discusses the gene ontology (GO) and how machine learning can play a role in evaluating protein protein interactions (PPIs).

Whilst at the Alzheimer’s Society Annual Conference (22–23 May, London, UK), we had the pleasure of speaking to Simon Lovestone, a Professor of Translational Neuroscience at the University of Oxford (UK), to hear more about his talk on ‘Dementia – Big problem; Big Data – Big solution?’

In this #NCTalks podcast recorded at the event, Sharon Salt (Editor) speaks to Simon to find out more about big data in dementia, including an overview of the talk given and how scientists can do more big data research. Listen to our podcast below to find out more.

View more podcasts, news and exclusive interviews at www.neuro-central.com

At the American Academy of Neurology’s 70th Annual Meeting (21–27 April, CA, USA), we spoke to Aleksandar Videnovic, a neurologist at Massachusetts General Hospital (MA, USA), about what a career in clinical trials involves. Aleksandar is also an Associate Professor of Neurology at Harvard Medical School (MA, USA).

In this #NCTalks podcast recorded at the event, Lauren Pulling (Publisher) speaks to Aleksandar to learn more about how to start a career in clinical trials, common challenges involved, rewarding aspects and advice for those thinking of starting a career in clinical trials. Listen to our podcast below to find out more.

View more podcasts, news and exclusive interviews at www.neuro-central.com

At the American Academy of Neurology’s 70th Annual Meeting (21–27 April, CA, USA), we spoke to Alexander Videnovic, a neurologist at Massachusetts General Hospital (MA, USA), about what a career in clinical trials involves. Alexander is also an Associate Professor of Neurology at Harvard Medical School (MA, USA).

In this #NCTalks podcast recorded at the event, Lauren Pulling (Publisher) speaks to Alexander to learn more about how to start a career in clinical trials, common challenges involved, rewarding aspects and advice for those thinking of starting a career in clinical trials. Listen to our podcast below to find out more.

View more podcasts, news and exclusive interviews at www.neuro-central.com

In this latest edition of NCTalks, Sharon Salt (Editor) speaks with Jens Kuhle, a neurologist at the University Hospital Basel, Switzerland. Jens is the head of the multiple sclerosis (MS) center at the hospital and runs a research group called ‘Translational Biomarkers and Biobanking’.

In this podcast, Jens speaks about monitoring MS using blood neurofilament light protein and how this could impact the way we monitor and treat MS. Jens also discusses how he overcame the hurdle of measuring neurofilament in the blood and what the next steps are for his team.

In this latest edition of NCTalks, Lauren Pulling (Publisher) speaks to Giovanni Baranello, a Pediatric Neurologist working at the Carlo Besta Neurological Institute (Milan, Italy). Giovanni is the principal investigator of the FIREFISH clinical trial, a preliminary study investigating the safety and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy.

In this podcast recorded at the American Academy of Neurology’s 70th Annual Meeting (April 21–27, CA, USA), Giovanni speaks about the FIREFISH trial and the mechanisms of RO7034067. Giovanni also discusses part II of the study and what the next steps include, and where the field could be in 5–10 years’ time.

View more podcasts, news and exclusive interviews at www.neuro-central.com

As part of our Spotlight, we present this interview with Cory Muraco who discusses his interest in chromatography, the technologies he uses and his top three tips for chromatographic method development.

As part of our focus, In the Zone: old vs new technologies, we present this podcast where we talk to Franklin Spriggs (Director of Large Molecule Services, KCAS) about his experience with investing in different technologies, and the key questions that need to be addressed when making any decision between different technologies. To find out more, visit: http://bit.ly/2rwG1fZ

Last week we had the pleasure of attending the American Academy of Neurology’s 70th Annual Meeting (April 21–27, CA, USA), where we spoke to Robert Fox, from the Mellen Center for Multiple Sclerosis at the Cleveland Clinic (OH, USA), about the Phase II SPRINT-MS trial of ibudilast in progressive multiple sclerosis.

In this #NCTalks podcast recorded at the event, Lauren Pulling (Publisher) speaks to Robert, who is the Protocol Principal Investigator in the trial, to learn more about the current landscape that led to this research and potential treatment regimens. Listen to our podcast below to find out more.

View more podcasts, news and exclusive interviews at www.neuro-central.com

Whilst at the Alzheimer’s Research UK (ARUK) Conference (20–21 March, London, UK), Lauren Pulling (Publisher) spoke to Giovanna Malluci, a Professor of Clinical Neurosciences at the University of Cambridge (UK) and Consultant Neurologist specializing in dementia. Giovanna is also the Associate Director of the Cambridge Center of the UK Dementia Research Institute (DRI).

In this #NCTalks podcast recorded at the ARUK Conference, Giovanna speaks about translating innovation from lab to clinic across the UK DRI, promising dementia research themes and what the dementia research landscape could look like in 10 years' time.

View more podcasts, news and exclusive interviews at www.neuro-central.com